Floating tablets of hydralazine hydrochloride: optimization and evaluation
Hydralazine hydrochloride has a half-life of 2 to 4 hours with an oral bioavailability of 26-50%. Since hydralazine has a demethylating effect on various suppressor genes, it can be used in various types of cancer to support chemotherapy. The purpose of this study was to optimize and evaluate floati...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
2013-12-01
|
| Seria: | Brazilian Journal of Pharmaceutical Sciences |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000400021&lng=en&tlng=en |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|